why no comments on the new S-1; this is actually very decent news for MMTC - a definitive step in the right direction - surely not the last of the dilution, but at least somone is willing to put some funding into the company.
Clearly Frank and Brennan intend to bring this concept to fruition with their own funds if necessary. Brennan has a solid record of building high-tech companies and launching IPO's to the big boards. I am dismayed by the company's lack of IR response, but am inclined to think that their technology will attract funding if they continue getting certifications for the priority pathogens.
Lots of bashing going on via the various boards, but the leverage of this company's IP compared to the expense and time requirements of the current methods represents a huge advantage over the status quo. Risky, yes, but the MIT-1000 is a machine that represents a giant leap forward in its sector.
Barring news, it will sink further. Might buy in soon. Been watching since .07's.